drugset / Trial / NCT03975205
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Phase 0
Unknown
500 enrolled
Sutphin Drugs
Bharath Charitable Cancer Hospital and Institute · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Doxil or Doxorubicin to be administered was administered in a dose of 50 mg/m2 as infusion over 15 minutes. Blood samples to be obtained at 0, 1, 2, 3, 4, 8, 12, 24, 48 and 72 hours
Timeline
- Start
- 2019-07-01
- Primary completion
- 2019-10-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 50 mg/m2 | Intravenous |